Search alternatives:
significant progressive » significant progress (Expand Search), significant protective (Expand Search), significant processes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
progressive decrease » progressive decline (Expand Search)
Showing 1,721 - 1,740 results of 2,072 for search '(( significant decrease decrease ) OR ( significant progressive decrease ))~', query time: 0.36s Refine Results
  1. 1721
    Image 8_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 8_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  2. 1722
    Image 5_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 5_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  3. 1723
    Image 2_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 2_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  4. 1724
    Image 3_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 3_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  5. 1725
    Image 4_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 4_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  6. 1726
    Image 11_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 11_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  7. 1727
    Image 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  8. 1728
    Image 10_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 10_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  9. 1729
    Image 7_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 7_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  10. 1730
    Image 6_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 6_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  11. 1731
    DataSheet1_SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice.docx

    DataSheet1_SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice.docx by Nerea Martos-Guillami (19809315)

    Published 2024
    “…</p>Results<p>Semaglutide combined with ramipril and/or empagliflozin significantly decreased albuminuria but only when combined with both compounds, semaglutide further decreased blood glucose, glomerular hyperfiltration in male mice and glomerular mesangial matrix expansion. …”
    Save to List
    Saved in:
  12. 1732
    Image 2_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.jpeg

    Image 2_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.jpeg by Zetong Zheng (22069658)

    Published 2025
    “…Immunohistochemistry of human ovarian sections showed that AQP2 levels decreased as follicles progressed from primordial to antral stages. …”
    Save to List
    Saved in:
  13. 1733
    Image 1_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.tif

    Image 1_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.tif by Zetong Zheng (22069658)

    Published 2025
    “…Immunohistochemistry of human ovarian sections showed that AQP2 levels decreased as follicles progressed from primordial to antral stages. …”
    Save to List
    Saved in:
  14. 1734
    Table 1_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.docx

    Table 1_Aquaporin 2 is differentially expressed in granulosa cells of various stages of human follicles and is regulated by luteinizing hormone.docx by Zetong Zheng (22069658)

    Published 2025
    “…Immunohistochemistry of human ovarian sections showed that AQP2 levels decreased as follicles progressed from primordial to antral stages. …”
    Save to List
    Saved in:
  15. 1735
    Table 2_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx

    Table 2_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx by Panke Su (22636301)

    Published 2025
    “…High-risk patients, identified by the signature, showed significantly decreased stromal, immune, and combined scores; increased tumor purity (P< 0.001); a reduced prevalence of various immune cell types; diminished immune cell activity; and decreased expression of immune checkpoint genes. …”
    Save to List
    Saved in:
  16. 1736
    Data Sheet 1_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx

    Data Sheet 1_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx by Panke Su (22636301)

    Published 2025
    “…High-risk patients, identified by the signature, showed significantly decreased stromal, immune, and combined scores; increased tumor purity (P< 0.001); a reduced prevalence of various immune cell types; diminished immune cell activity; and decreased expression of immune checkpoint genes. …”
    Save to List
    Saved in:
  17. 1737
    Table 1_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx

    Table 1_Prognostic alternative mRNA splicing in lung adenocarcinoma.xlsx by Panke Su (22636301)

    Published 2025
    “…High-risk patients, identified by the signature, showed significantly decreased stromal, immune, and combined scores; increased tumor purity (P< 0.001); a reduced prevalence of various immune cell types; diminished immune cell activity; and decreased expression of immune checkpoint genes. …”
    Save to List
    Saved in:
  18. 1738
    Supplementary file 1_Cyperotundone promotes chemosensitivity of breast cancer via SRSF1.tif

    Supplementary file 1_Cyperotundone promotes chemosensitivity of breast cancer via SRSF1.tif by Chao Li (145513)

    Published 2025
    “…Knockdown of SRSF1 significantly decreased expression of full-length MYO1B protein in drug-resistant BC cells (P < 0.05). …”
    Save to List
    Saved in:
  19. 1739
    Table 1_Cyperotundone promotes chemosensitivity of breast cancer via SRSF1.docx

    Table 1_Cyperotundone promotes chemosensitivity of breast cancer via SRSF1.docx by Chao Li (145513)

    Published 2025
    “…Knockdown of SRSF1 significantly decreased expression of full-length MYO1B protein in drug-resistant BC cells (P < 0.05). …”
    Save to List
    Saved in:
  20. 1740
    Table 2_Ipriflavone ameliorates intervertebral disc degeneration by inhibiting osteoporosis of vertebral body and pyroptosis of the nucleus pulposus in instability of lumbar spine and diabetic mice.xlsx

    Table 2_Ipriflavone ameliorates intervertebral disc degeneration by inhibiting osteoporosis of vertebral body and pyroptosis of the nucleus pulposus in instability of lumbar spine... by Qi Sun (127)

    Published 2025
    “…Furthermore, IP ameliorated the cartilage extracellular matrix degradation, significantly increased Aggrecan and Col II expression and decreased the expression of MMP13 and ADAMTS-4. …”
    Save to List
    Saved in:

Search Tools: